Bennett S, Gao J, Osen E, Myuran T
Department of Otolaryngology and Head and Neck Surgery, Mid and South Essex NHS Foundation Trust, Broomfield Hospital, Chelmsford, UK.
J Laryngol Otol. 2022 Nov;136(11):1066-1070. doi: 10.1017/S0022215121002656. Epub 2021 Oct 1.
The clinical value of tonsillectomy continues to cause much debate, despite tonsil disease representing a significant burden to patients, caregivers and healthcare systems. This study assessed the long-term effect of adenotonsillectomy or tonsillectomy on the Paediatric Throat Disorders Outcome Test ('T-14'), a validated tool used to objectively assess obstructive and infective symptoms in paediatric throat disorders.
Patients aged under 16 years undergoing adenotonsillectomy or tonsillectomy were recruited consecutively from 2018 into our prospective observational study. The Paediatric Throat Disorders Outcome Test questionnaire was completed by the children's caregivers pre-operatively ( = 80), and at 21 days ( = 68) and 2 years ( = 66) post-operatively.
Significant reductions were noted in mean total Paediatric Throat Disorders Outcome Test scores at 21 days and 2 years post-operatively ( ≤ 0.003).
Our results provide supporting evidence that paediatric adenotonsillectomy or tonsillectomy significantly improves quality of life up to two years post-operatively, and therefore remains a valuable use of healthcare resources.
尽管扁桃体疾病给患者、照料者和医疗系统带来了沉重负担，但扁桃体切除术的临床价值仍备受争议。本研究评估了腺样体扁桃体切除术或扁桃体切除术对儿童咽喉疾病结局测试（“T-14”）的长期影响，该测试是一种经过验证的工具，用于客观评估儿童咽喉疾病中的阻塞性和感染性症状。
2018年起，我们连续招募了16岁以下接受腺样体扁桃体切除术或扁桃体切除术的患者，进行前瞻性观察研究。儿童照料者在术前（n = 80）、术后21天（n = 68）和术后2年（n = 66）完成儿童咽喉疾病结局测试问卷。
术后21天和2年时，儿童咽喉疾病结局测试平均总分显著降低（P≤0.003）。
我们的结果提供了支持性证据，表明儿童腺样体扁桃体切除术或扁桃体切除术在术后两年内可显著改善生活质量，因此仍是一种有价值的医疗资源利用方式。
